YDES · NASDAQ · Biotechnology

YD Bio (YDES)

Builds cancer-testing and ophthalmology programs alongside clinical-trial drug supply.

$3.74
Pre-market−0.16 (−4.10%)
At close$3.90(+3.31%)

Something off on this page? Send us feedback.

EPSReportedEstimate

FY24
Reported−$0.43
Estimate
Surprise

RevenueReportedEstimate

FY24
Reported$0
Estimate
Surprise

History

Fiscal yearEstimateReportedSurprise
2024−$0.43
Fiscal yearEPS estEPSSurpriseRevenue estRevenueSurprise
2024−$0.43$0